48 related articles for article (PubMed ID: 2624682)
1. The Targeting of Native Proteins to the Endoplasmic Reticulum-Associated Degradation (ERAD) Pathway: An Expanding Repertoire of Regulated Substrates.
Kumari D; Brodsky JL
Biomolecules; 2021 Aug; 11(8):. PubMed ID: 34439852
[TBL] [Abstract][Full Text] [Related]
2. Structural changes induced by acidic pH in human apolipoprotein B-100.
Fernández-Higuero JA; Benito-Vicente A; Etxebarria A; Milicua JC; Ostolaza H; Arrondo JL; Martín C
Sci Rep; 2016 Nov; 6():36324. PubMed ID: 27824107
[TBL] [Abstract][Full Text] [Related]
3. Structural analysis of APOB variants, p.(Arg3527Gln), p.(Arg1164Thr) and p.(Gln4494del), causing Familial Hypercholesterolaemia provides novel insights into variant pathogenicity.
Fernández-Higuero JA; Etxebarria A; Benito-Vicente A; Alves AC; Arrondo JL; Ostolaza H; Bourbon M; Martin C
Sci Rep; 2015 Dec; 5():18184. PubMed ID: 26643808
[TBL] [Abstract][Full Text] [Related]
4. Impact of myeloperoxidase-LDL interactions on enzyme activity and subsequent posttranslational oxidative modifications of apoB-100.
Delporte C; Boudjeltia KZ; Noyon C; Furtmüller PG; Nuyens V; Slomianny MC; Madhoun P; Desmet JM; Raynal P; Dufour D; Koyani CN; Reyé F; Rousseau A; Vanhaeverbeek M; Ducobu J; Michalski JC; Nève J; Vanhamme L; Obinger C; Malle E; Van Antwerpen P
J Lipid Res; 2014 Apr; 55(4):747-57. PubMed ID: 24534704
[TBL] [Abstract][Full Text] [Related]
5. Low-density lipoprotein modified by myeloperoxidase in inflammatory pathways and clinical studies.
Delporte C; Van Antwerpen P; Vanhamme L; Roumeguère T; Zouaoui Boudjeltia K
Mediators Inflamm; 2013; 2013():971579. PubMed ID: 23983406
[TBL] [Abstract][Full Text] [Related]
6. Molecular structure of low density lipoprotein: current status and future challenges.
Prassl R; Laggner P
Eur Biophys J; 2009 Feb; 38(2):145-58. PubMed ID: 18797861
[TBL] [Abstract][Full Text] [Related]
7. Liquid chromatographic analysis of amino acids: using dimethylamino-azobenzenesulfonyl chloride and Hypersil ODS column to analyze the composition of apo B peptides.
Yang CY; Yang T; Yeh BK
J Protein Chem; 1993 Feb; 12(1):11-4. PubMed ID: 8427628
[TBL] [Abstract][Full Text] [Related]
8. Isolation and characterization of sulfhydryl and disulfide peptides of human apolipoprotein B-100.
Yang CY; Kim TW; Weng SA; Lee BR; Yang ML; Gotto AM
Proc Natl Acad Sci U S A; 1990 Jul; 87(14):5523-7. PubMed ID: 2115173
[TBL] [Abstract][Full Text] [Related]
9. [Conformation of apolipoprotein B-100--structure and functional classification of low density lipoproteins].
Titov VN
Biokhimiia; 1996 Jan; 61(1):3-23. PubMed ID: 8679776
[TBL] [Abstract][Full Text] [Related]
10. Limited tryptic digestion of human serum low-density lipoprotein: isolation and characterisation of the protein-deficient particle and of its apoprotein.
Chapman MJ; Goldstein S; Mills GL
Eur J Biochem; 1978 Jul; 87(3):475-88. PubMed ID: 210015
[TBL] [Abstract][Full Text] [Related]
11. Structure and conformational analysis of lipid-associating peptides of apolipoprotein B-100 produced by trypsinolysis.
Yang CY; Kim TW; Pao Q; Chan L; Knapp RD; Gotto AM; Pownall HJ
J Protein Chem; 1989 Dec; 8(6):689-99. PubMed ID: 2624682
[TBL] [Abstract][Full Text] [Related]
12. Only the two end helixes of eight tandem amphipathic helical domains of human apo A-I have significant lipid affinity. Implications for HDL assembly.
Palgunachari MN; Mishra VK; Lund-Katz S; Phillips MC; Adeyeye SO; Alluri S; Anantharamaiah GM; Segrest JP
Arterioscler Thromb Vasc Biol; 1996 Feb; 16(2):328-38. PubMed ID: 8620350
[TBL] [Abstract][Full Text] [Related]
13. Structure and orientation of apo B-100 peptides into a lipid bilayer.
Lins L; Brasseur R; Rosseneu M; Yang CY; Sparrow DA; Sparrow JT; Gotto AM; Ruysschaert JM
J Protein Chem; 1994 Jan; 13(1):77-88. PubMed ID: 8011074
[TBL] [Abstract][Full Text] [Related]
14. Evidence for lipid-dependent structural changes in specific domains of apolipoprotein B100.
Chauhan V; Wang X; Ramsamy T; Milne RW; Sparks DL
Biochemistry; 1998 Mar; 37(11):3735-42. PubMed ID: 9521692
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
